Increased ACE-1:ACE-2 ratio is related to higher parenchymal Aβ and tau load (13) and overactive AT1R signaling correlates with oxidative stress, elevated Aβ and tau, and impaired cognition in AD (14). Here, MAPT is linked to Alzheimer disease.